These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31517431)

  • 1. Statins for primary prevention of cardiovascular disease and the risk of acute kidney injury.
    Coste J; Karras A; Rudnichi A; Dray-Spira R; Pouchot J; Giral P; Zureik M
    Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1583-1590. PubMed ID: 31517431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins for primary prevention and rhabdomyolysis: A nationwide cohort study in France.
    Coste J; Billionnet C; Rudnichi A; Pouchot J; Dray-Spira R; Giral P; Zureik M
    Eur J Prev Cardiol; 2019 Mar; 26(5):512-521. PubMed ID: 29799296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Efficacy of Statins for Prevention of Contrast-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease: A Network Meta-Analysis.
    Zhou X; Dai J; Xu X; Wang Z; Xu H; Chen J; Qiu Y; Mao W
    Angiology; 2019 Apr; 70(4):305-316. PubMed ID: 30261736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France.
    Giral P; Neumann A; Weill A; Coste J
    Eur Heart J; 2019 Nov; 40(43):3516-3525. PubMed ID: 31362307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do statins prevent acute kidney injury?
    Philips B; MacPhee I
    Expert Opin Drug Saf; 2015 Oct; 14(10):1547-61. PubMed ID: 26365784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of statins for primary prevention of cardiovascular disease and persistent physical disability in older adults.
    Zhou Z; Curtis AJ; Ernst ME; Ryan J; Zoungas S; Wolfe R; McNeil JJ; Murray AM; Reid CM; Chowdhury EK; Woods RL; Tonkin AM; Nelson MR
    Eur J Clin Pharmacol; 2022 Mar; 78(3):467-476. PubMed ID: 34698889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?
    Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
    Expert Opin Pharmacother; 2015; 16(10):1449-61. PubMed ID: 26037614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.
    Billings FT; Hendricks PA; Schildcrout JS; Shi Y; Petracek MR; Byrne JG; Brown NJ
    JAMA; 2016 Mar; 315(9):877-88. PubMed ID: 26906014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Short-Term Statin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography/Percutaneous Coronary Intervention: A Meta-Analysis of 21 Randomized Controlled Trials.
    Li H; Wang C; Liu C; Li R; Zou M; Cheng G
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):201-19. PubMed ID: 26899537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins.
    García Rodríguez LA; Herings R; Johansson S
    Pharmacoepidemiol Drug Saf; 2010 Dec; 19(12):1218-24. PubMed ID: 20922707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study.
    Yebyo HG; Aschmann HE; Puhan MA
    Ann Intern Med; 2019 Jan; 170(1):1-10. PubMed ID: 30508425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up study.
    Sasso FC; Lascar N; Ascione A; Carbonara O; De Nicola L; Minutolo R; Salvatore T; Rizzo MR; Cirillo P; Paolisso G; Marfella R;
    Cardiovasc Diabetol; 2016 Oct; 15(1):147. PubMed ID: 27733159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials.
    Bangalore S; Fayyad R; Hovingh GK; Laskey R; Vogt L; DeMicco DA; Waters DD;
    Am J Cardiol; 2014 Jun; 113(12):2018-20. PubMed ID: 24793673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin use and the risk of acute kidney injury in older adults.
    Tonelli M; Lloyd AM; Bello AK; James MT; Klarenbach SW; McAlister FA; Manns BJ; Tsuyuki RT; Hemmelgarn BR;
    BMC Nephrol; 2019 Mar; 20(1):103. PubMed ID: 30909872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling.
    Perera R; McFadden E; McLellan J; Lung T; Clarke P; Pérez T; Fanshawe T; Dalton A; Farmer A; Glasziou P; Takahashi O; Stevens J; Irwig L; Hirst J; Stevens S; Leslie A; Ohde S; Deshpande G; Urayama K; Shine B; Stevens R
    Health Technol Assess; 2015 Dec; 19(100):1-401, vii-viii. PubMed ID: 26680162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-potency statins increase the risk of acute kidney injury: evidence from a large population-based study.
    Corrao G; Soranna D; Casula M; Merlino L; Porcellini MG; Catapano AL
    Atherosclerosis; 2014 May; 234(1):224-9. PubMed ID: 24681912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database.
    Hippisley-Cox J; Coupland C
    BMJ; 2010 May; 340():c2197. PubMed ID: 20488911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).
    Toso A; Leoncini M; Maioli M; Tropeano F; Di Vincenzo E; Villani S; Bellandi F
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1421-9. PubMed ID: 25523533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Rosuvastatin in Contrast-Induced Acute Kidney Injury in the Elderly: Post Hoc Analysis of the PRATO-ACS Trial.
    Tropeano F; Leoncini M; Toso A; Maioli M; Dabizzi L; Biagini D; Villani S; Bellandi F
    J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):159-66. PubMed ID: 26307206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants.
    Yebyo HG; Aschmann HE; Kaufmann M; Puhan MA
    Am Heart J; 2019 Apr; 210():18-28. PubMed ID: 30716508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.